You Searched For "coronavirus vaccine SII" and got 20 results
Sort By:
Should you be worried about the potential side-effects of the Covishield vaccine?
Thrombosis with Thrombocytopenia Syndrome (TTS), can lead to dangerously low blood clot and platele…
Serum Institute of India can resume clinical trial of Oxford COVID-19 vaccine, says DCGI
SII has also been asked to submit to the DCGI's office details of medication used in accordance wit…
PTI
Oxford COVID-19 vaccine human trials to continue in India, says SII
The testing of Covid-19 vaccine being developed by AstraZeneca and University of Oxford has been pu…
DGCI gives nod to SII's proposal to manufacture vaccine against omicron for test, analysis
"... the new coronavirus variant 'omicron' has already been reported in more than 60 countries and…
PTI
Oxford and Serum Institute of India begin human trials of a new COVID-19 vaccine in Australia
According to Sumi Biswas, CEO SpyBiotech, the Serum Institute of India — which is running the ph…
COVID-19 cases in India cross 32 lakh mark, recovery rate rises to 75.92%
With 67,151 fresh coronavirus infections in 24 hours, India's tally mounted to 32,34,474 on Wednesd…
India COVID-19 vaccine tracker: SII requests DCGI to alter clinical norms, Epygen Biotech enters vaccine race
India’s COVID-19 doubling rate has reduced to 70.4 days from 25.5 days earlier, according to the Mi…
Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market
SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…
India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates
The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …
Oxford COVID-19 vaccine: SII pauses trials in India following show-cause notice
"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. W…
SII's Oxford-Astra Zeneca COVID-19 vaccine to cost $3-4 to Indian government, price likely to be double in private markets
Only after meeting their requirements, "the private market will open up where the pricin…
PTI
No vaccine approval yet, drug regulator analysing SII, Bharat Biotech data
New Delhi, Dec 30 (IANS) The analysis of the additional data and information submitted by Serum Ins…
Centre seeks 300-400 mn vaccine doses, says SII's Poonawalla
Pune, Nov 28 (IANS) The Government of India is looking at getting 300-400 million doses of coronavi…
SII to resume Covid vaccine trials once DCGI gives nod (Ld)
New Delhi, Sep 12 (IANS) Serum Institute of India (SII) said on Saturday it will resume trials in I…
SII aims to have 100m doses of AstraZeneca vaccine ready by Dec (Ld)
New Delhi, Nov 13 (IANS) Serum Institute of India (SII) is ramping up production of AstraZeneca's C…
COVID-19 vaccine updates in India: Oxford’s COVID-19 vaccine trials can be over by December, if SII doesn’t go for emergency licence
Scientists are still looking for a cure for the deadly coronavirus, which has infected millions of …
Adar Poonawalla says SII will seek emergency use authorisation for AstraZeneca COVID-19 vaccine in two weeks
Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting …
The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla
The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vac…
India begins its COVID-19 vaccination drive — here’s a look at how the world’s largest vaccine rollout is set to take place
After a year since the coronavirus pandemic began, claiming over 1.5 lakh lives in India, the momen…
Co-WIN app to be used for COVID-19 vaccine — how to register, documents required, and everything you need to know
The Co-WIN app will feature five modules - Administrator module, Registration module, Vaccinat…